chartexchange

ANAB261218P00070000
ANAB Dec 18 2026 70.00 Put
optionOPRA

EOD
—USD0OI
Loading…
Underlying
Underlying Price
$47.40
Type
Put
Strike
70
Expiration
Dec 18, 2026
DTE
29d
Moneyness
ITM
Intrinsic
$22.60
ANAB 70 Put Across Expirations
ExpirationDTELastChangeVolOpen Int
Nov 20, 20261d——00
Nov 20, 20261d$15.65+0.00%10
Dec 18, 202629d——00
Feb 19, 202792d$22.59+16.44%30
May 21, 2027183d——00
ANAB Nearby Strikes · Dec 18, 2026
StrikeLastChangeVolOpen IntMoneyness
40 P$2.83+23.04%3139OTM
45 P$4.93+6.02%1148OTM
50 P$6.10+0.00%11799ITM
55 P——00ITM
60 P$15.35+0.00%2020ITM
65 P——00ITM
70 P——00ITM
ANAB Profile

founded in 2005, anaptysbio, inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (shm) for antibody discovery and optimization. anaptysbio is building a pipeline of novel therapeutic antibody product candidates, including differentiated programs in cancer immunotherapy, inflammation, muscle wasting disorders, fibrosis and antibody-drug conjugate applications. anaptysbio's proprietary shm-xel platform, which couples fully human antibody libraries with in vitro somatic hypermutation (shm) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies. by harnessing the natural mechanism of antibody maturation under controlled conditions, shm-xel allows for the selection of optimal antibody properties such as high affinity, function, cross-reactivity, epitope diversity and manufacturability. the c